China Pharma Pure Powder manufacturer

Chiauranib CS2164 Multi-Target Protein Kinase Inhibitors Anticancer

Product Details:
Place of Origin: Xi'An, China
Brand Name: Wango
Certification: BP USP EP
Model Number: WG-0213
Payment & Shipping Terms:
Minimum Order Quantity: 10 grams every time
Price: 60-70usd/gram Can be nogotiable according to the quantity .
Packaging Details: 5kgs/Tin&2Tins/Carton by TNT or DHL
Delivery Time: 3-5 days
Payment Terms: L/C, T/T, Western Union
Supply Ability: 10,000 gram of every month from reseach experiments !

Detail Information

Colour: White Powder Function: Anti-cancer
MOQ: 10 Gram Name: Chiauranib
Function: Breast Cancer
High Light:

Chiauranib Protein Kinase Inhibitors

,

CS2164 Protein Kinase Inhibitors

,

WG-0213 Kinase Inhibitors Drugs

Product Description

Chiauranib CS2164 Multi-Target Protein Kinase Inhibitors Anticancer biggest manufacturer of China !

 

Chiauranib CS2164 Multi-Target Protein Kinase Inhibitors Anticancer 0Due to tumor heterogeneity, drug resistance to targeted therapy is a common issue afflicting agents that target a single pathway.

Chiauranib, a highly selective Aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor, was developed by Chipscreen Biosciences specifically to address drug resistance.Chiauranib exerts a comprehensive anti-tumor effect by a triple-pathway mechanism that simultaneously inhibits tumor angiogenesis, prevents tumor cell mitosis, and modulates the tumor microenvironment. With a favorable safety profile, Chiauranib has outperformed drugs with a similar mechanism in its pharmacodynamic activity in animal studies.

 

Chiauranib CS2164 Multi-Target Protein Kinase Inhibitors Anticancer 1

Figure. Triple-pathway anti-tumor mechanisms of Chiauranib

 

  • In June 2018, approvals for Phase II/III clinical trials of Chiauranib were granted by the CFDA. Phase II clinical trials of the drug for a variety of tumors have now been completed.
  • In December 2020, Chiauranib was included in the “Breakthrough Therapy Category” for the treatment of small cell lung cancer by the Center for Drug Evaluation (CDE) of NMPA.
  • In March 2021, Chiauranib was included in the “Breakthrough Therapy Category” for the treatment of ovarian cancer by the CDE of NMPA.
  • In March 2021, an application for a pivotal Phase III clinical trial of Chiauranib in the treatment of small cell lung cancer was approved by the NMPA.
  • In April 2021, an application for a pivotal Phase III clinical trial of Chiauranib in the treatment of ovarian cancer was approved by the NMPA.
  • In April 2021, an investigational new drug (IND) application for a Phase Ib/II clinical trial of Chiauranib was approved by the FDA, the first approved trial indication for Chiauranib in the U.S.
  • In May 2021, an application for the Phase II clinical trial of Chiauranib for triple-negative breast cancer was accepted by the NMPA.

 

FAQ
 


Q1: How to confirm the Product Quality before placing orders?


A: By sending you our available samples.
Or if you have special requirement on the goods, we can prepare samples according to your requirement for your confirmation.

Q2: Can you supply free samples?


A: Yes, we can provide some free sample, but the shipping cost should be on the customers' account. You can either pay the shipping cost or arrange a courier to collect the samples.

Q3: What's the MOQ?


A: For the high value product, our MOQ starts from 1g and generally starts from 10g.
For other low value product, our MOQ starts from 100g and 1kg.

Q4: How to place order and make payment?


A: You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by TradeManager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.

Q5: How do you treat quality complaint?


A: All our products are strictly tested by our QC, and confirmed by QA; unqualified material will not be released to customer.
In case any quality problem is confirmed to be caused by us, we will replace the goods or refund your payment immediately.

 

 

 

Get in touch with us

Enter Your Message

You Might Be Into These